| US 7,565,200 B2 | ||
| Systems and methods for selecting stimulation sites and applying treatment, including treatment of symptoms of Parkinson's disease, other movement disorders, and/or drug side effects | ||
| Allen Wyler, Seattle, Wash. (US); and Brad Fowler, Woodinville, Wash. (US) | ||
| Assigned to Advanced Neuromodulation Systems, Inc., Plano, Tex. (US) | ||
| Filed on Nov. 12, 2004, as Appl. No. 10/986,614. | ||
| Prior Publication US 2006/0106431 A1, May 18, 2006 | ||
| Int. Cl. A61N 1/18 (2006.01) | ||
| U.S. Cl. 607—48 [607/45; 607/118] | 16 Claims |
| 1. A method for treating neurological dysfunction, comprising:
determining that a patient's neurological disorder, not caused by external electrical stimulation, affects an aspect of the
patient's movement other than the patient's gait and the patient's oral functioning;
based at least in part on determining that the neurological disorder affects an aspect of a patient's movement other than
the patient's gait and the patient's oral functioning, treating the patient's disorder by implanting at least one electrode
device so that a first electrical contact is over one of the motor cortex, the prefrontal cortex and the supplementary motor
area of the patient's brain, and a second electrical contact is over another of the motor cortex, the prefrontal cortex and
the supplementary motor area, at least one of the first and second electrical contacts being positioned at a region of the
patient's brain that is located between the interhemispheric fissure and the Sylvian fissure of the patient's brain, both
the first and second electrical contacts being positioned within the patient's skull, proximate the dura mater and outside
a cortical surface of the patient's brain; and
applying electrical stimulation to the patient's brain via the at least one electrode device, independently of the patient's
brain activity level immediately prior to applying the stimulation.
|